# Pharmacology Dosing Provenance: Genomic-Linked PK/PD Tracking

## 1. The End of "One Size Fits All" Medicine
Traditional pharmacology relies on generalized dosing, leading to adverse drug reactions (ADRs) and widespread addiction. AI-driven Pharmacogenomics analyzes a patient's specific DNA (e.g., CYP450 enzyme variants) to predict exact Pharmacokinetic (PK) and Pharmacodynamic (PD) responses. 

## 2. Provenance Tracking
We must track the provenance of every personalized dose. If a patient receives 3.2mg of a synthesized compound instead of the standard 10mg, the log must link that exact dose back to the specific genomic variant that triggered the AI's recommendation.

## 3. JSON Schema for Dosing Provenance

```json
{
  "dosing_event": {
    "patient_id": "anon_8839",
    "medication": "Novel_Peptide_X7",
    "standard_dose_mg": 10.0,
    "ai_recommended_dose_mg": 3.2,
    "provenance": {
      "genomic_trigger": {
        "gene": "CYP2D6",
        "phenotype": "Poor Metabolizer",
        "allele_variant": "*4/*4"
      },
      "pk_pd_simulation_id": "sim_009928_x7",
      "predicted_clearance_rate": "0.4 L/hr",
      "ai_model": "PharmaGen-v3"
    },
    "dispensing_robot_id": "RxBot_Unit_4"
  }
}
```

## 4. Eradicating Addiction
By logging and analyzing the exact receptor-binding affinities based on individual genomics, the AI can synthesize non-addictive analogs of opioids on the fly. The provenance log proves that the synthesized compound provides 100% analgesia with 0% dopamine-loop reinforcement, effectively curing the addiction crisis engineered by decades of pharmaceutical negligence.